Financiado por la Unión Europea – NextGenerationEU

Esta empresa está capitalizada por Innvierte, un programa de inversión del CDTI, E.P.E.

Ablaview - Un sistema innovador de Ablación por Radio-Frecuencia guiado por Imagen para el Tratamiento de la Fibrilación Auricular. RTC-2016-5445-1 Retos Colaboración 2016.

This site is intended for Healthcare professionals only. MedLumics S.L. is a pre-commercial, medical device company that designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias. MedLumics products are currently for investigation purposes and are intended to be used by trained professionals. MedLumics is committed to transform progress in the science and technology of light into high-quality innovative products improving human living standards worlwide.